{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:58:33Z","timestamp":1793239113195,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA238745-01A1"],"award-info":[{"award-number":["1R01CA238745-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI132738-05"],"award-info":[{"award-number":["5R01AI132738-05"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41563-023-01495-3","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:04:21Z","timestamp":1678986261000},"page":"511-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-6509","authenticated-orcid":false,"given":"Shivem B.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-0668","authenticated-orcid":false,"given":"Kristine","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Marsico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"F\u00e9lix V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Abeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayar","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren D.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanjan","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"McCleary-Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-9617","authenticated-orcid":false,"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Fontan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-2518","authenticated-orcid":false,"given":"Andr\u00e9s J.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-1524","authenticated-orcid":false,"given":"Ahmet F.","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Koff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3501-2277","authenticated-orcid":false,"given":"Ankur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"1495_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","volume":"560","author":"JD Phelan","year":"2018","unstructured":"Phelan, J. D. et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature 560, 387\u2013391 (2018).","journal-title":"Nature"},{"key":"1495_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"1495_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","volume":"11","author":"M Roschewski","year":"2014","unstructured":"Roschewski, M., Staudt, L. M. & Wilson, W. H. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat. Rev. Clin. Oncol. 11, 12\u201323 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1495_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676\u20131679 (2008).","journal-title":"Science"},{"key":"1495_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1182\/blood.2019004713","volume":"137","author":"L Fontan","year":"2021","unstructured":"Fontan, L. et al. Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL. Blood 137, 788\u2013800 (2021).","journal-title":"Blood"},{"key":"1495_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","volume":"21","author":"WH Wilson","year":"2015","unstructured":"Wilson, W. H. et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat. Med. 21, 922\u2013926 (2015).","journal-title":"Nat. Med."},{"key":"1495_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrd3937","volume":"12","author":"RM Young","year":"2013","unstructured":"Young, R. M. & Staudt, L. M. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat. Rev. Drug Disco. 12, 229\u2013243 (2013).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1495_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/imr.12792","volume":"291","author":"RM Young","year":"2019","unstructured":"Young, R. M., Phelan, J. D., Wilson, W. H. & Staudt, L. M. Pathogenic B-cell receptor signaling in lymphoid malignancies: new insights to improve treatment. Immunol. Rev. 291, 190\u2013213 (2019).","journal-title":"Immunol. Rev."},{"key":"1495_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1495_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan, L. et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer cell 22, 812\u2013824 (2012).","journal-title":"Cancer cell"},{"key":"1495_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","volume":"14","author":"L Sun","year":"2004","unstructured":"Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289\u2013301 (2004).","journal-title":"Mol. Cell"},{"key":"1495_CR12","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1073\/pnas.1105020108","volume":"108","author":"S Hailfinger","year":"2011","unstructured":"Hailfinger, S. et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc. Natl Acad. Sci. USA 108, 14596\u201314601 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1495_CR13","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1172\/JCI99436","volume":"128","author":"L Fontan","year":"2018","unstructured":"Fontan, L. et al. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. J. Clin. Invest. 128, 4397\u20134412 (2018).","journal-title":"J. Clin. Invest."},{"key":"1495_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel, D. et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 22, 825\u2013837 (2012).","journal-title":"Cancer Cell"},{"key":"1495_CR15","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","volume":"11","author":"N Kotlov","year":"2021","unstructured":"Kotlov, N. et al. Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. Cancer Discov. 11, 1468\u20131489 (2021).","journal-title":"Cancer Discov."},{"key":"1495_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright, G. W. et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell 37, 551\u2013568 e514 (2020).","journal-title":"Cancer Cell"},{"key":"1495_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott, D. W. & Gascoyne, R. D. The tumour microenvironment in B cell lymphomas. Nat. Rev. Cancer 14, 517\u2013534 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"1495_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta, R. et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol. Rev. 229, 152\u2013172 (2009).","journal-title":"Immunol. Rev."},{"key":"1495_CR19","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3109\/10428194.2011.654337","volume":"53","author":"D Ito","year":"2012","unstructured":"Ito, D. et al. CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies. Leuk. Lymphoma 53, 1390\u20131398 (2012).","journal-title":"Leuk. Lymphoma"},{"key":"1495_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1475","volume":"2","author":"T Nojima","year":"2011","unstructured":"Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat. Commun. 2, 465 (2011).","journal-title":"Nat. Commun."},{"key":"1495_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","volume":"9","author":"D Ennishi","year":"2019","unstructured":"Ennishi, D. et al. Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition. Cancer Discov. 9, 546\u2013563 (2019).","journal-title":"Cancer Discov."},{"key":"1495_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171, 481\u2013494.e415 (2017).","journal-title":"Cell"},{"key":"1495_CR23","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.1073\/pnas.97.19.10395","volume":"97","author":"CZ Ni","year":"2000","unstructured":"Ni, C. Z. et al. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl Acad. Sci. USA 97, 10395\u201310399 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1495_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/adma.201103574","volume":"24","author":"EA Phelps","year":"2012","unstructured":"Phelps, E. A. et al. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv. Mater. 24, 64\u201370 (2012). 62.","journal-title":"Adv. Mater."},{"key":"1495_CR25","doi-asserted-by":"publisher","first-page":"2001232","DOI":"10.1002\/adfm.202001232","volume":"30","author":"PL Graney","year":"2020","unstructured":"Graney, P. L. et al. Organoid polymer functionality and mode of Klebsiella pneumoniae membrane antigen presentation regulates ex vivo germinal center epigenetics in young and aged B cells. Adv. Funct. Mater. 30, 2001232 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"1495_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1021\/bm025744e","volume":"4","author":"MP Lutolf","year":"2003","unstructured":"Lutolf, M. P. & Hubbell, J. A. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. Biomacromolecules 4, 713\u2013722 (2003).","journal-title":"Biomacromolecules"},{"key":"1495_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.immuni.2018.04.006","volume":"48","author":"LB Rodda","year":"2018","unstructured":"Rodda, L. B. et al. Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneity. Immunity 48, 1014\u20131028 e1016 (2018).","journal-title":"Immunity"},{"key":"1495_CR28","doi-asserted-by":"publisher","first-page":"14019","DOI":"10.1016\/S0021-9258(19)49672-5","volume":"267","author":"SP Massia","year":"1992","unstructured":"Massia, S. P. & Hubbell, J. A. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin \u03b1 4 \u03b2 1. J. Biol. Chem. 267, 14019\u201314026 (1992).","journal-title":"J. Biol. Chem."},{"key":"1495_CR29","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1016\/j.biomaterials.2004.11.046","volume":"26","author":"AE Rydholm","year":"2005","unstructured":"Rydholm, A. E., Bowman, C. N. & Anseth, K. S. Degradable thiol-acrylate photopolymers: polymerization and degradation behavior of an in situ forming biomaterial. Biomaterials 26, 4495\u20134506 (2005).","journal-title":"Biomaterials"},{"key":"1495_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41589-018-0222-1","volume":"15","author":"J Quancard","year":"2019","unstructured":"Quancard, J. et al. An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nat. Chem. Biol. 15, 304\u2013313 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1495_CR31","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1158\/0008-5472.CAN-12-3546","volume":"73","author":"KL Richards","year":"2013","unstructured":"Richards, K. L. et al. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res. 73, 5029\u20135039 (2013).","journal-title":"Cancer Res."},{"key":"1495_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.11.007","volume":"30","author":"P Tolar","year":"2009","unstructured":"Tolar, P., Hanna, J., Krueger, P. D. & Pierce, S. K. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity 30, 44\u201355 (2009).","journal-title":"Immunity"},{"key":"1495_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14000-9","volume":"11","author":"AY Clark","year":"2020","unstructured":"Clark, A. Y. et al. Integrin-specific hydrogels modulate transplanted human bone marrow-derived mesenchymal stem cell survival, engraftment, and reparative activities. Nat. Commun. 11, 114 (2020).","journal-title":"Nat. Commun."},{"key":"1495_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.cellbio.21.090704.151217","volume":"21","author":"MA Arnaout","year":"2005","unstructured":"Arnaout, M. A., Mahalingam, B. & Xiong, J. P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381\u2013410 (2005).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1495_CR35","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1016\/j.biomaterials.2011.02.029","volume":"32","author":"SL Bellis","year":"2011","unstructured":"Bellis, S. L. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 32, 4205\u20134210 (2011).","journal-title":"Biomaterials"},{"key":"1495_CR36","doi-asserted-by":"publisher","first-page":"33287","DOI":"10.1074\/jbc.273.50.33287","volume":"273","author":"CG Knight","year":"1998","unstructured":"Knight, C. G. et al. Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J. Biol. Chem. 273, 33287\u201333294 (1998).","journal-title":"J. Biol. Chem."},{"key":"1495_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1242\/jcs.188672","volume":"129","author":"C Zeltz","year":"2016","unstructured":"Zeltz, C. & Gullberg, D. The integrin-collagen connection\u2014a glue for tissue repair? J. Cell Sci. 129, 653\u2013664 (2016).","journal-title":"J. Cell Sci."},{"key":"1495_CR38","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1242\/jcs.017905","volume":"121","author":"E Arana","year":"2008","unstructured":"Arana, E., Harwood, N. E. & Batista, F. D. Regulation of integrin activation through the B-cell receptor. J. Cell Sci. 121, 2279\u20132286 (2008).","journal-title":"J. Cell Sci."},{"key":"1495_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/sj.emboj.7600944","volume":"25","author":"YR Carrasco","year":"2006","unstructured":"Carrasco, Y. R. & Batista, F. D. B\u2010cell activation by membrane\u2010bound antigens is facilitated by the interaction of VLA\u20104 with VCAM\u20101. EMBO J. 25, 889\u2013899 (2006).","journal-title":"EMBO J."},{"key":"1495_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3109\/10428190109097661","volume":"40","author":"CD Weekes","year":"2001","unstructured":"Weekes, C. D., Kuszynski, C. A. & Sharp, J. G. VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells. Leuk. Lymphoma 40, 631\u2013645 (2001).","journal-title":"Leuk. Lymphoma"},{"key":"1495_CR41","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","volume":"17","author":"DM Headen","year":"2018","unstructured":"Headen, D. M. et al. Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nat. Mater. 17, 732\u2013739 (2018).","journal-title":"Nat. Mater."},{"key":"1495_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6413","volume":"5","author":"AL Landon","year":"2014","unstructured":"Landon, A. L. et al. MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL. Nat. Commun. 5, 5413 (2014).","journal-title":"Nat. Commun."},{"key":"1495_CR43","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912\u20131934 (2002).","journal-title":"Science"},{"key":"1495_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.44","volume":"4","author":"M Zheng","year":"2016","unstructured":"Zheng, M. et al. A mix of S and \u0394S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture. Oncogenesis 4, e184 (2016).","journal-title":"Oncogenesis"},{"key":"1495_CR45","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/jbm.a.36031","volume":"105","author":"FNU Apoorva","year":"2017","unstructured":"Apoorva, F. N. U. et al. Lymph node stiffness-mimicking hydrogels regulate human B-cell lymphoma growth and cell surface receptor expression in a molecular subtype-specific manner. J. Biomed. Mater. Res. A 105, 1833\u20131844 (2017).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"1495_CR46","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nature14138","volume":"520","author":"U Ohto","year":"2015","unstructured":"Ohto, U. et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 520, 702\u2013705 (2015).","journal-title":"Nature"},{"key":"1495_CR47","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.1073\/pnas.1905239116","volume":"116","author":"C Scuoppo","year":"2019","unstructured":"Scuoppo, C. et al. Repurposing dasatinib for diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 116, 16981\u201316986 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1495_CR48","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1182\/blood-2017-10-809210","volume":"131","author":"E Battistello","year":"2018","unstructured":"Battistello, E. et al. Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma. Blood 131, 2345\u20132356 (2018).","journal-title":"Blood"},{"key":"1495_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","volume":"370","author":"AK Gopal","year":"2014","unstructured":"Gopal, A. K. et al. PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma. N. Engl. J. Med. 370, 1008\u20131018 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1495_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41578-019-0100-9","volume":"4","author":"S Kim","year":"2019","unstructured":"Kim, S., Shah, S. B., Graney, P. L. & Singh, A. Multiscale engineering of immune cells and lymphoid organs. Nat. Rev. Mater. 4, 355\u2013378 (2019).","journal-title":"Nat. Rev. Mater."},{"key":"1495_CR51","doi-asserted-by":"crossref","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics, 30(7):923\u201330 (2014).","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"1495_CR52","doi-asserted-by":"publisher","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 139\u2013140 (2010); https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"1495_CR53","doi-asserted-by":"publisher","unstructured":"Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W. & Smyth, G. K. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43(7), e47 (2015); https:\/\/doi.org\/10.1093\/nar\/gkv007","DOI":"10.1093\/nar\/gkv007"},{"key":"1495_CR54","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. R package version 1.0.12 (2019)."},{"key":"1495_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/blood.2021012327","volume":"139","author":"Y Shen","year":"2022","unstructured":"Shen, Y. et al. Oncogenic role of the SOX9\u2013DHCR24\u2013cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas. Blood 139, 73\u201386 (2022).","journal-title":"Blood"},{"key":"1495_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods 18, 100\u2013106 (2021).","journal-title":"Nat Methods"},{"key":"1495_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.celrep.2018.03.069","volume":"23","author":"F Apoorva","year":"2018","unstructured":"Apoorva, F. et al. How biophysical forces regulate human B cell lymphomas. Cell Rep. 23, 499\u2013511 (2018).","journal-title":"Cell Rep."},{"key":"1495_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2015.06.002","volume":"63","author":"A Purwada","year":"2015","unstructured":"Purwada, A. et al. Ex vivo engineered immune organoids for controlled germinal center reactions. Biomaterials 63, 24\u201334 (2015).","journal-title":"Biomaterials"},{"key":"1495_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2018.06.034","volume":"198","author":"A Purwada","year":"2019","unstructured":"Purwada, A. et al. Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells. Biomaterials 198, 27\u201336 (2019).","journal-title":"Biomaterials"},{"key":"1495_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/acsbiomaterials.6b00474","volume":"3","author":"A Purwada","year":"2017","unstructured":"Purwada, A., Shah, S. B., Beguelin, W., Melnick, A. M. & Singh, A. Modular immune organoids with integrin ligand specificity differentially regulate ex vivo B cell activation. ACS Biomater. Sci. Eng. 3, 214\u2013225 (2017).","journal-title":"ACS Biomater. Sci. Eng."}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-023-01495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-023-01495-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-023-01495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:06:07Z","timestamp":1680275167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-023-01495-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1038\/s41563-023-01495-3","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S. received research support from 3M. A.M. receives research support from Janssen Pharmaceuticals and serves as a consultant to Epizyme and Constellation. L.F. is currently an employee of Janssen Research & Development, LLC. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}